UBS AM’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-73,720
| Closed | -$1.76M | – | 2812 |
|
|
2021
Q1 | $1.76M | Sell |
73,720
-1,802
| -2% | -$33.5K | ﹤0.01% | 1808 |
|
|
2020
Q4 | $1.1M | Sell |
75,522
-4,048
| -5% | -$53.7K | ﹤0.01% | 1940 |
|
|
2020
Q3 | $1.13M | Buy |
79,570
+2,878
| +4% | +$44K | ﹤0.01% | 1790 |
|
|
2020
Q2 | $1.13M | Buy |
76,692
+9,252
| +14% | +$94K | ﹤0.01% | 1741 |
|
|
2020
Q1 | $278K | Buy |
67,440
+12,466
| +23% | +$58.4K | ﹤0.01% | 2180 |
|
|
2019
Q4 | $264K | Sell |
54,974
-1,440
| -3% | -$7.94K | ﹤0.01% | 2399 |
|
|
2019
Q3 | $342K | Buy |
56,414
+4,468
| +9% | +$27.9K | ﹤0.01% | 2409 |
|
|
2019
Q2 | $337K | Buy |
51,946
+9,519
| +22% | +$67.1K | ﹤0.01% | 2372 |
|
|
2019
Q1 | $301K | Sell |
42,427
-20,053
| -32% | -$132K | ﹤0.01% | 2314 |
|
|
2018
Q4 | $304K | Hold |
62,480
| – | – | ﹤0.01% | 2213 |
|
|
2018
Q3 | $459K | Sell |
62,480
-5,807
| -9% | -$42.6K | ﹤0.01% | 2123 |
|
|
2018
Q2 | $436K | Buy |
68,287
+18,887
| +38% | +$125K | ﹤0.01% | 2155 |
|
|
2018
Q1 | $269K | Hold |
49,400
| – | – | ﹤0.01% | 2258 |
|
|
2017
Q4 | $206K | Buy |
49,400
+26,000
| +111% | +$156K | ﹤0.01% | 2305 |
|
|
2017
Q3 | $225K | Hold |
23,400
| – | – | ﹤0.01% | 2200 |
|
|
2017
Q2 | $277K | Buy |
+23,400
| New | +$299K | ﹤0.01% | 2074 |
|
|
2016
Q4 | – | Sell |
-20,400
| Closed | -$241K | – | 2744 |
|
|
2016
Q3 | $241K | Buy |
20,400
+6,300
| +45% | +$60.8K | ﹤0.01% | 2373 |
|
|
2016
Q2 | $123K | Hold |
14,100
| – | – | ﹤0.01% | 2561 |
|
|
2016
Q1 | $74K | Hold |
14,100
| – | – | ﹤0.01% | 2595 |
|
|
2015
Q4 | $109K | Hold |
14,100
| – | – | ﹤0.01% | 2651 |
|
|
2015
Q3 | $111K | Hold |
14,100
| – | – | ﹤0.01% | 2600 |
|
|
2015
Q2 | $128K | Hold |
14,100
| – | – | ﹤0.01% | 2651 |
|
|
2015
Q1 | $183K | Buy |
14,100
+700
| +5% | +$9.15K | ﹤0.01% | 2512 |
|
|
2014
Q4 | $182K | Hold |
13,400
| – | – | ﹤0.01% | 2501 |
|
|
2014
Q3 | $120K | Hold |
13,400
| – | – | ﹤0.01% | 2484 |
|
|
2014
Q2 | $181K | Buy |
+13,400
| New | +$140K | ﹤0.01% | 2435 |
|
UBS AM's GNMK Position: Q2 2021 in Review
UBS AM sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 73,720 shares — an estimated $1.76M sold.
UBS AM first reported a position in GNMK in Q2 2014 and held it in 26 quarters. The position peaked at $1.76M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- UBS AM reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- UBS AM sold 73,720 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.76M.
- UBS AM first reported a position in GenMark Diagnostics, Inc in Q2 2014 and held it in 26 quarters.
- UBS AM's GenMark Diagnostics, Inc position peaked at $1.76M in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on UBS AM's 13F filing for Q2 2021, filed 16 Aug 2021.